Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Upcoming IPO
Afc Gamma, Inc. (AFCG)
Property Solutions Acquisition II (PSAGU)
Khosla Ventures Acquisition Co. (KVSA)
Twin Ridge Capital Acquisition (TRCA.U)
Rxr Acquisition (RXRAU)
Interprivate II Acquisition (IPVA.U)
Interprivate III Financial Partners (IPVF.U)
Aurora Acquisition Corp. (AURCU)
ALTIMAR ACQUISITION CORP. III (ATAQU)
Lerer Hippeau Acquisition Corp. (LHAA)
Universe Pharmaceuticals (UPC)
Roblox Corporation (RBLX)
First High-school Education Group Co., Ltd. (FHS)
Coupang, Inc. (CPNG)
Hayward Holdings, Inc. (HAYW)
Priced IPO
Innovage Holding Corp (INNV)
Oscar Health, Inc. (OSCR)
Score Media And Gaming, Inc. (SCR)
Briacell Therapeutics Corp. (BCTX)
Clip Interactive, LLC (AUDD)
Greenbox Pos (GBOX)
Virpax Pharmaceuticals, Inc. (VRPX)
Urban-gro (UGRO)
Neximmune, Inc. (NEXI)
Longeveron (LGVN)
Talis Biomedical Corporation (TLIS)
Decibel Therapeutics, Inc. (DBTX)
Loandepot, Inc. (LDI)
Bumble, Inc. (BMBL)
Apria, Inc. (APR)
Signify Health, Inc.. (SGFY)
Bioventus Inc. (BVS)
Biophytis SA (BPTS)
Vallon Pharmaceuticals (VLON)
Viant Technology Inc. (DSP)
More companies

908 Devices Inc. (MASS)

Sector - Healthcare

Price chart

+114.7%
Return from IPO

Company News

IPO Profile

About company

They have developed an innovative suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Leveraging their proprietary platform technology, they make the extraordinary analytical power of Mass Spec available in devices that are significantly smaller and more accessible than conventional laboratory instruments. Their Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, industrial biotech, forensics and adjacent markets. As they democratize the extraordinary power of Mass Spec, they believe their technology platform can expand in future opportunities far beyond the current $8 billion market for Mass Spec and associated front-end separations. They estimate their total addressable market, or TAM, for their devices to be $4.8 billion in 2020 growing to an estimated $22 billion over the next five years.
Industry
Measuring & Controlling Devices
CEO CFO
Kevin J. Knopp Joseph H. Griffith IV
Employees Founded
96 2012

Contacts

Address: 645 Summer Street, Boston, MA 02210, US

Telephone: (857) 254-1500

Web page: http://www.908devices.com

IPO information

Expected Date 12/18/2020
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range $15.00-$17.00
Share prices ($)

Shares & Volumes

Shares Initial (MM) 6.25
Shares Revised (MM) 6.5
Expected offer amount (MM) $100
Realized offer amount(MM) $130

Financial Data (last reporting year)

Market Cap (MM) $480.1
Revenues (MM) $30.9
Net Income (Loss) (MM) $-3.2

Voting

What do you think will happen with the MASS share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: Cowen

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
Underwriters
Cowen/ SVB Leerink William Blair/ Stifel
CO-Managers
-

Sector: Healthcare

Tweets about $MASS

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats